1. Anthrax: developing drugs for prophylaxis of inhalational anthrax Publication: Silver Spring, MD : Center for Drug Evaluation and Research, May 2018 Subject(s): Anthrax -- drug therapyAnthrax -- prevention & controlAntibiotic ProphylaxisClinical Trials as TopicDrug Evaluation, Preclinical -- standardsDrugs, Investigational -- therapeutic useInhalation ExposureAdultChildEndpoint DeterminationMicrobial Sensitivity Tests -- standardsPediatricsProduct Surveillance, Postmarketing -- standardsResearch DesignHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
2. Extending expiration dates of doxycycline tablets and capsules in strategic stockpiles: guidance for government public health and emergency response stakeholders Publication: Silver Spring, MD : Center for Drug Evaluation and Research, April 2019 Subject(s): Anthrax -- drug therapyCivil DefenseDoxycycline -- supply & distributionDoxycycline -- therapeutic usePost-Exposure ProphylaxisStrategic StockpileBiological AvailabilityDrug StabilityDrug StorageLegislation, DrugBiological AvailabilityHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.United States.
